Assessing all aspects of HR/HC operations and transformation to prepare an assessment that expands on the initial baseline, interim, and final assessments of the hiring and retention in HR/HC…
Ended Awarded Last action
- Contract number
- 75F40123F19003
- Awardee
-
Eastern Research Group Inc. UEI DK4TBEJRAR56
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,695,726
Award facts
- Contract value 100% obligated
- $1,695,726.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$50,481 | |
| Other Administrative Action | $0 | |
| Original award | $1,746,208 |
About this award
The Food and Drug Administration issued a BPA call to Eastern Research Group Inc. on September 8, 2023, with a ceiling value of $1,695,726.33 for assessments of FDA's HR and Human Capital operations and transformation initiatives.
The call, placed under the Multiple Award Schedule (MAS), covers baseline, interim, and final assessments of hiring and retention within FDA's HR/HC components. Work is performed in Silver Spring, Maryland. The ultimate completion date is September 30, 2025.
Government invoicing in FY2024 totaled $692 thousand across 2.9 FTEs and 6,093 contractor hours, yielding a derived hourly rate of $113.58. The prime self-performed all reported labor with no subcontractors. The contract is being closed out via de-obligation of remaining funds.
Description
Assessing all aspects of HR/HC operations and transformation to prepare an assessment that expands on the initial baseline, interim, and final assessments of the hiring and retention in HR/HC components of FDA.
Quick answers
Who was awarded contract 75F40123F19003?
75F40123F19003 was awarded to Eastern Research Group Inc. by Food and Drug Administration (Department of Health and Human Services) on September 8, 2023.
How much is contract 75F40123F19003 worth?
The government has obligated $1,695,726 on 75F40123F19003.
Is contract 75F40123F19003 an order under another contract?
Yes. 75F40123F19003 is a BPA call under GS21F001BA-75F40123A00001, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19003 competed?
The extent of competition for 75F40123F19003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award